Quinidine	quinidine	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Long-term	long-term	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
quinidine	quinidine	O	O	OTHERS	I
was	was	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
persistent	persistent	O	O	O	O
elevation	elevation	O	O	O	O
of	of	O	O	O	O
serum	serum	O	O	O	O
concentrations	concentrations	O	O	O	O
of	of	O	O	O	O
SGOT	sgot	O	O	O	O
,	,	O	O	O	O
lactic	lactic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
dehydrogenase	dehydrogenase	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
alkaline	alkaline	CHEMICALS	O	OTHERS	I
phosphatase	phosphatase	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Liver	liver	O	O	O	O
biopsy	biopsy	O	O	O	O
showed	showed	O	O	O	O
active	active	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Discontinuance	discontinuance	O	O	O	O
of	of	O	O	O	O
quinidine	quinidine	O	O	OTHERS	I
therapy	therapy	O	O	O	O
led	led	O	O	O	O
to	to	O	O	O	O
normalization	normalization	O	O	O	O
of	of	O	O	O	O
liver	liver	O	O	O	O
function	function	O	O	O	O
tests	tests	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
challenge	challenge	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
quinidine	quinidine	O	O	OTHERS	I
caused	caused	O	O	O	O
clinical	clinical	O	O	O	O
symptoms	symptoms	O	O	O	O
and	and	O	O	O	O
abrupt	abrupt	O	O	O	O
elevation	elevation	O	O	O	O
of	of	O	O	O	O
SGOT	sgot	O	O	O	O
,	,	O	O	O	O
alkaline	alkaline	CHEMICALS	O	OTHERS	I
phosphatase	phosphatase	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
lactic	lactic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
dehydrogenase	dehydrogenase	O	O	O	O
values	values	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
this	this	O	O	O	O
patient	patient	O	O	O	O
had	had	O	O	O	O
quinidine	quinidine	O	O	OTHERS	I
hepatotoxicity	hepatotoxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
believe	believe	O	O	O	O
that	that	O	O	O	O
this	this	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
case	case	O	O	O	O
reported	reported	O	O	O	O
with	with	O	O	O	O
liver	liver	O	O	O	O
biopsy	biopsy	O	O	O	O
documentation	documentation	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
report	report	O	O	O	O
also	also	O	O	O	O
suggests	suggests	O	O	O	O
that	that	O	O	O	O
,	,	O	O	O	O
even	even	O	O	O	O
after	after	O	O	O	O
long-term	long-term	O	O	O	O
administration	administration	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
hepatic	hepatic	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
is	is	O	O	O	O
reversible	reversible	O	O	O	O
.	.	O	O	O	O

